Tag Archives: FDA

ACC resorts to smear tactics to defend its cash cows, formaldehyde and styrene

Richard Denison, Ph.D., is a Senior Scientist.

An increasingly common tactic in modern bare-knuckle politics is to divert attention away from your own weakness or vulnerability by loudly – and falsely – accusing your opponent of having that very defect you possess but won’t admit to.

That Rovian tactic was on display last week, with the American Chemistry Council (ACC) as the accuser, and the National Toxicology Program (NTP) as its “opponent.”  Mind you, NTP is the nation’s leading authoritative body on cancer-causing chemicals.

The precipitating event?  NTP’s long-overdue release of its 12th Report on Carcinogens (RoC).  Among other additions NTP made since its last report was published way back in 2005, it had the audacity – according to ACC – to:

  • upgrade its classification of formaldehyde to “Known to be a human carcinogen,” from its earlier classification (dating back to 1981) as “Reasonably anticipated to be a human carcinogen,” and
  • for the first time include styrene on its list of chemicals linked to cancer, classifying it as “reasonably anticipated to be a human carcinogen.”

The accusation hurled at NTP was this gem from ACC President and CEO, Cal Dooley:

“We are extremely concerned that politics may have hijacked the scientific process and believe this report by HHS is an egregious contradiction to what the President said early in his administration, ‘…That science and the scientific process must inform and guide decisions of my administration…’.”

Talk about the pot calling the kettle black (per the “second, subtler interpretation” of that phrase).

Read More »

Posted in Health Policy, TSCA | Also tagged , , , , | Comments closed

Why is OMB blocking EPA from using even its limited authority under TSCA?

Richard Denison, Ph.D., is a Senior Scientist.

On May 12 of this year, the Environmental Protection Agency (EPA) sent a proposed rule to the Office of Management and Budget’s (OMB’s) Office of Information and Regulatory Affairs (OIRA) for its review, which is supposed to be completed within 90 days.  The proposed rule is not considered a major rule, is classified as “not economically significant,” imposes no unfunded mandates and is unequivocally allowed under EPA’s statutory authority under the Toxic Substances Control Act (TSCA).

The proposed rule would establish a so-called “chemicals of concern” list and populate it with one chemical and two chemical categories.  All of these chemicals are well-studied, already widely identified to be chemicals of significant concern and subject to numerous regulations by governmental bodies both in the U.S. and abroad.

Yet, as of today – more than seven months after receiving the draft of the proposed rule from EPA – OMB has not allowed EPA to release it for public notice and comment.

In 1976, when passing TSCA, Congress gave EPA the express authority to establish and populate a “chemicals of concern” list.  There’s simply no excuse for OMB’s delay.  Read More »

Posted in Health Policy, TSCA | Also tagged , , , , , , , , | Comments closed

Are we ready to get sensible about triclosan use?

Cal Baier-AndersonCal Baier-Anderson, Ph.D., is a Health Scientist.

Yesterday the Washington Post reported that the Food and Drug Administration (FDA) is acknowledging that new research raises "valid concerns" about the possible health effects of triclosan, an antimicrobial chemical that can be found in dozens of consumer products as diverse as soaps, personal care products, cutting boards, plastic sandals and even bath towels.

Originally developed as a surgical scrub for use by doctors and nurses, the burgeoning uses of this pesticidal chemical have hugely expanded human and environmental exposures.  With little evidence of any actual public health benefits from such uses, FDA along with the Environmental Protection Agency (EPA) and the Consumer Product Safety Commission (CPSC) should move quickly to limit triclosan use.  Only those uses that have a demonstrable public health benefit, when weighed against potential health and environmental risks, should be allowed. Read More »

Posted in Health Science | Also tagged , , , | Comments closed

Superficial science in new nano sunscreen report

Richard Denison, Ph.D., is a Senior Scientist.

I hate to say it, but Friends of the Earth, Consumers Union, and the International Center for Technology Assessment (ICTA) have done a disservice to good science and policy with their new superficial report Manufactured Nanomaterials and Sunscreens: Top Reasons for PrecautionRead More »

Posted in Nanotechnology | Also tagged , | Comments closed

Rebuilding the Consumer Product Safety Commission's Nano Tool Box

John BalbusCal Baier-Anderson, Ph.D., is a Health Scientist.

I have just finished reading yet another depressing/infuriating publication by the Woodrow Wilson Center's Project on Emerging Nanotechnologies. The new report delineates the many limitations faced by the Consumer Product Safety Commission (CPSC) in addressing nanotechnology health risks.  The law governing the CPSC has significant weaknesses that prevent it from meeting critical needs, such as constraints on the ability to collect data, require reporting of known hazards, order recalls and promulgate mandatory safety standards.

Read More »

Posted in Health Policy, Health Science, Nanotechnology, TSCA | Also tagged , | Comments closed

Burning Questions: Are Sunscreens Containing Nanomaterials Safe?

John BalbusCal Baier-Anderson, Ph.D., is a Health Scientist.

Ah, summer!  It’s a great time to be outdoors, enjoying the warm, sunny weather.  Before you go outside, be sure to grab your sunscreen, that essential product that protects against skin cancer and sun damage.  But which kind of sunscreen is best?  There is a mesmerizing array of sunscreen options, but for our purposes let’s limit the question to one:  Nano or not nano?

Read More »

Posted in Health Science, Nanotechnology | Also tagged | Comments closed

The Next Mile Marker on the Road to High Throughput In Vitro Screening?

John BalbusJohn Balbus, M.D., M.P.H., is Chief Health Scientist.

A new paper by Shaw et al., published in May in the Proceedings of the National Academy of Sciences, “suggests a generalizable and scalable method for the systematic characterization and comparison of novel nanomaterials” using high throughput in vitro tests.  Does this mean that the National Academy of Sciences’ vision for toxicity testing in the 21st century – proposed for conventional chemicals – is already here for nanomaterials?  Not quite.  Read More »

Posted in Health Science, Nanotechnology | Also tagged , , | Comments closed

What Was the White House Thinking?

Richard Denison, Ph.D., is a Senior Scientist.

It’s been a few months now since the White House took the unusual step of articulating some “Principles for Nanotechnology EH&S Oversight.” Given recent events, it’s worth again reflecting on this official memorandum, which was signed by the heads of the White House’s Council on Environmental Quality (CEQ) and Office of Science and Technology Policy (OSTP) and sent to the heads of all federal agencies and departments.

Despite the title, it’s very hard not to read this document as one intended primarily to throw up barriers to effective oversight. Read More »

Posted in Health Policy, Nanotechnology, TSCA | Also tagged | Comments closed
  • About this blog

    Science, health, and business experts at Environmental Defense Fund comment on chemical and nanotechnology issues of the day.

    Effective April, 2009, we have expanded the scope of our blog to encompass our work and perspectives on both chemicals and nanomaterials.

    Our work: Chemicals

  • Get blog posts by email

    Subscribe via RSS

  • Categories

  • Filter posts by tags


    • aggregate exposure (9)
    • American Chemistry Council (ACC) (49)
    • arsenic (3)
    • asthma (3)
    • Australia (1)
    • biomonitoring (9)
    • bipartisan (6)
    • bisphenol A (14)
    • BP Oil Disaster (18)
    • Canada (7)
    • carbon nanotubes (24)
    • carcinogen (19)
    • Carcinogenic Mutagenic or Toxic for Reproduction (CMR) (11)
    • CDC (6)
    • Chemical Assessment and Management Program (ChAMP) (13)
    • chemical identity (30)
    • chemical testing (1)
    • Chicago Tribune (6)
    • children's safety (18)
    • China (10)
    • computational toxicology (9)
    • Confidential Business Information (CBI) (40)
    • conflict of interest (1)
    • consumer products (43)
    • Consumer Specialty Products Association (CSPA) (4)
    • contamination (4)
    • cumulative exposure (4)
    • data requirements (41)
    • diabetes (4)
    • DNA methylation (4)
    • DuPont (11)
    • endocrine disruption (23)
    • epigenetics (3)
    • exposure and hazard (38)
    • FDA (8)
    • flame retardants (17)
    • formaldehyde (13)
    • front group (13)
    • Globally Harmonized System (GHS) (5)
    • Government Accountability Office (5)
    • hazard (5)
    • High Production Volume (HPV) (22)
    • in vitro (13)
    • in vivo (10)
    • industry tactics (38)
    • inhalation (18)
    • IUR/CDR (25)
    • Japan (3)
    • lead (6)
    • mercury (4)
    • methylmercury (2)
    • microbiome (3)
    • nanosilver (6)
    • National Academy of Sciences (NAS) (16)
    • National Institute for Occupational Safety and Health (NIOSH) (7)
    • National Institute of Environmental Health Sciences (NIEHS) (5)
    • National Nanotechnology Initiative (NNI) (6)
    • obesity (6)
    • Occupational Safety and Health Administration (OSHA) (3)
    • Office of Information and Regulatory Affairs (OIRA) (3)
    • Office of Management and Budget (OMB) (12)
    • Office of Pollution Prevention and Toxics (OPPT) (3)
    • oil dispersant (18)
    • PBDEs (14)
    • Persistent Bioaccumulative and Toxic (PBT) (20)
    • pesticides (7)
    • phthalates (14)
    • polycyclic aromatic hydrocarbons (PAH) (5)
    • prenatal (6)
    • prioritization (31)
    • risk assessment (60)
    • Safe Chemicals Act (24)
    • Safer Chemicals Healthy Families (33)
    • Significant New Use Rule (SNUR) (15)
    • Small business (1)
    • South Korea (3)
    • styrene (5)
    • Substances of Very High Concern (SVHC) (12)
    • test rule (13)
    • tributyltin (3)
    • trichloroethylene (TCE) (3)
    • Turkey (3)
    • U.S. states (12)
    • vulnerable populations (1)
    • worker safety (21)
  • Archives